BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35075971)

  • 21. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.
    Sakakibara A; Kohno K; Iwakoshi A; Moritani S; Fujishiro A; Kito K; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
    Pathol Int; 2020 Feb; 70(2):116-122. PubMed ID: 31894883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How I Diagnose Primary Mediastinal (Thymic) Large B-Cell Lymphoma.
    Ondrejka SL; Ott G
    Am J Clin Pathol; 2021 Sep; 156(4):497-512. PubMed ID: 34398178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 27 cases].
    Shi QY; Feng X; Chen H; Ma HH; Lu ZF; Shi QL; Zhou XJ; Shen Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):607-612. PubMed ID: 28910870
    [No Abstract]   [Full Text] [Related]  

  • 24. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas.
    Maracaja DLV; Puthenpura V; Pels SG; O'Malley DP; Sklar JL; Finberg KE; Xu ML
    Appl Immunohistochem Mol Morphol; 2020; 28(10):725-730. PubMed ID: 31789821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
    Dunleavy K; Grant C; Eberle FC; Pittaluga S; Jaffe ES; Wilson WH
    Curr Hematol Malig Rep; 2012 Sep; 7(3):241-7. PubMed ID: 22833351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma.
    Leithäuser F; Bäuerle M; Huynh MQ; Möller P
    Blood; 2001 Nov; 98(9):2762-70. PubMed ID: 11675349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.
    Chapuy B; Stewart C; Dunford AJ; Kim J; Wienand K; Kamburov A; Griffin GK; Chen PH; Lako A; Redd RA; Cote CM; Ducar MD; Thorner AR; Rodig SJ; Getz G; Shipp MA
    Blood; 2019 Dec; 134(26):2369-2382. PubMed ID: 31697821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
    Eberle FC; Salaverria I; Steidl C; Summers TA; Pittaluga S; Neriah SB; Rodriguez-Canales J; Xi L; Ylaya K; Liewehr D; Dunleavy K; Wilson WH; Hewitt SM; Raffeld M; Gascoyne RD; Siebert R; Jaffe ES
    Mod Pathol; 2011 Dec; 24(12):1586-97. PubMed ID: 21822207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
    Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
    Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
    Shi Y; Su H; Song Y; Jiang W; Sun X; Qian W; Zhang W; Gao Y; Jin Z; Zhou J; Jin C; Zou L; Qiu L; Li W; Yang J; Hou M; Xiong Y; Zhou H; Du X; Wang X; Peng B
    EBioMedicine; 2020 Apr; 54():102731. PubMed ID: 32304999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mediastinal large B-cell lymphoma].
    Artemieva AS; Semiglazova TY; Frank GA
    Vopr Onkol; 2015; 61(2):280-8. PubMed ID: 26087612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Unclassified B-cell lymphomas with "grey zone" characteristics].
    Chen DB; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.
    Camus V; Stamatoullas A; Mareschal S; Viailly PJ; Sarafan-Vasseur N; Bohers E; Dubois S; Picquenot JM; Ruminy P; Maingonnat C; Bertrand P; Cornic M; Tallon-Simon V; Becker S; Veresezan L; Frebourg T; Vera P; Bastard C; Tilly H; Jardin F
    Haematologica; 2016 Sep; 101(9):1094-101. PubMed ID: 27479820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
    Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma.
    Melzner I; Weniger MA; Menz CK; Möller P
    Leukemia; 2006 Jan; 20(1):157-8. PubMed ID: 16331280
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic significance of immunophenotypes and a nodular pattern in primary mediastinal large B-cell lymphoma.
    Maeshima AM; Taniguchi H; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Kobayashi Y; Tobinai K; Kushima R
    Pathol Int; 2014 Aug; 64(8):382-7. PubMed ID: 25143126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.